Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Current Value
$37.291 Year Return
Current Value
$37.291 Year Return
Market Cap
$14.35B
P/E Ratio
-6.4
1Y Stock Return
-51.66%
1Y Revenue Growth
-44.06%
Dividend Yield
0.00%
Price to Book
1.2
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CMG | -0.03% | $80.02B | +33.62% | 0.00% |
X | -0.04% | $8.76B | +13.32% | 0.51% |
AHR | -0.06% | $4.30B | +134.17% | 2.69% |
MMC | 0.11% | $108.41B | +10.89% | 1.37% |
CPB | 0.16% | $12.96B | +7.08% | 3.40% |
CNA | 0.19% | $13.16B | +23.03% | 3.61% |
KO | -0.24% | $269.63B | +7.86% | 3.07% |
CME | 0.28% | $82.76B | +9.21% | 1.98% |
BAH | -0.28% | $17.62B | +9.13% | 1.47% |
MSDL | 0.28% | $1.83B | +0.66% | 7.26% |
TRGP | -0.31% | $44.39B | +132.49% | 1.34% |
AZO | -0.44% | $52.52B | +16.10% | 0.00% |
STVN | 0.54% | $4.95B | -32.48% | 0.32% |
SRRK | -0.57% | $2.61B | +134.91% | 0.00% |
CMTL | 0.58% | $84.44M | -76.16% | 0.00% |
BRO | -0.65% | $31.27B | +47.55% | 0.49% |
USAP | 0.70% | $412.06M | +176.63% | 0.00% |
SIGI | -0.72% | $5.90B | -4.96% | 1.47% |
WLKP | -0.74% | $796.39M | +4.00% | 8.34% |
ETR | 0.76% | $32.14B | +49.00% | 3.05% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PGR | -17.36% | $149.10B | +57.29% | 0.45% |
COR | -14.26% | $47.48B | +21.20% | 0.86% |
ALL | -13.74% | $52.06B | +45.67% | 1.85% |
ERII | -11.52% | $888.67M | -20.30% | 0.00% |
DRVN | -11.23% | $2.68B | +26.39% | 0.00% |
GAN | -10.91% | $83.39M | +21.19% | 0.00% |
CHD | -10.91% | $27.18B | +19.50% | 1.03% |
TMUS | -10.73% | $270.63B | +56.92% | 0.83% |
HUSA | -10.54% | $16.69M | -11.56% | 0.00% |
INSM | -10.30% | $13.19B | +202.50% | 0.00% |
AON | -10.19% | $82.00B | +16.33% | 0.70% |
NOC | -9.79% | $71.54B | +4.23% | 1.60% |
ACHC | -9.63% | $3.45B | -48.91% | 0.00% |
CBOE | -9.47% | $21.46B | +15.84% | 1.11% |
XGN | -9.47% | $62.26M | +127.74% | 0.00% |
MCK | -9.41% | $78.15B | +35.51% | 0.42% |
LLY | -9.20% | $692.74B | +23.14% | 0.71% |
NTGR | -8.74% | $695.37M | +91.07% | 0.00% |
PULM | -8.69% | $19.83M | +202.98% | 0.00% |
CWAN | -8.52% | $6.77B | +47.68% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CGNX | 46.08% | $6.73B | +6.19% | 0.78% |
BNTX | 45.75% | $25.51B | +9.51% | 0.00% |
IPG | 42.39% | $10.30B | -8.50% | 4.72% |
ZD | 42.28% | $2.37B | -14.73% | 0.00% |
RCKT | 41.21% | $1.20B | -39.83% | 0.00% |
COHU | 41.11% | $1.18B | -22.38% | 0.00% |
ZBRA | 40.38% | $19.72B | +71.93% | 0.00% |
DIOD | 40.17% | $2.53B | -20.36% | 0.00% |
TROW | 39.50% | $26.20B | +21.60% | 4.19% |
GT | 38.83% | $2.60B | -34.81% | 0.00% |
BWA | 38.61% | $7.25B | -2.62% | 1.34% |
RXRX | 38.49% | $1.80B | -4.13% | 0.00% |
AXL | 37.96% | $723.12M | -13.74% | 0.00% |
CRSP | 37.52% | $4.01B | -30.49% | 0.00% |
OUT | 37.27% | $3.11B | +52.98% | 6.41% |
UI | 37.15% | $20.80B | +201.03% | 0.70% |
KMT | 37.05% | $2.17B | +21.08% | 2.88% |
MATV | 36.68% | $678.65M | -4.95% | 3.16% |
TRMB | 36.52% | $17.01B | +61.09% | 0.00% |
IIPR | 36.46% | $3.01B | +33.85% | 7.00% |
Finnhub
The U.S. Centers for Disease Control and Prevention said on Wednesday it expects to see an increase in levels of COVID-19 and respiratory syncytial virus in the country in the coming weeks, as they...
SeekingAlpha
Following underperformance in Q2 2024, the Franklin Biotechnology Discovery Fund returned to strength in Q3 2024. Click here to read the full commentary.
Yahoo
Berenberg analyst Harry Gillis initiated coverage of Moderna (MRNA) with a Hold rating and $42 price target. The firm says mRNA will revolutionize the treatment of multiple diseases. However, the analyst prefers BioNTech (BNTX) for exposure relative to Moderna. Moderna is quickly spending its COVID cash and will not meet 2028 breakeven guidance, despite recent downgrades, the analyst tells investors in a research note. Berenberg says the company is more vulnerable to commercial pressure due to i
SeekingAlpha
SPDR® S&P Biotech ETF had its worst week since 2020, but the sector remains undervalued. Read why XBI is a strong buy for patient investors.
Yahoo
HSBC analyst Yifeng Liu upgraded Moderna (MRNA) to Buy from Hold with a price target of $58, down from $82. The recent share price weakness reflects worries over the company’s path back to growth story, the analyst tells investors in a research note. The firm says that if Moderna’s existing key pipeline products manage to launch successfully and RSV-vaccine recommendation pressure eases, there could be attractive upside potential for the stock. Published first on TheFly – the ultimate source for
Yahoo
Last week, some large European and U.S. vaccine maker stocks fell in reaction to Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human Services. Including Moderna Inc (NASDAQ:MRNA), several stocks witnessed a decline as Kennedy has been known to be against vaccines and has a track record of making false claims about vaccines, including the debunked idea that they cause autism. Goldman Sachs hosted an investor lunch with Moderna CEO Stéphane Bancel, President Stephen Hoge,
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -33.67% | $388.04M | 1.43% |
VIXY | -25.62% | $195.31M | 0.85% |
USDU | -21.52% | $201.97M | 0.5% |
UUP | -19.35% | $309.25M | 0.77% |
TAIL | -12.68% | $67.98M | 0.59% |
EQLS | -9.43% | $76.08M | 1% |
TBIL | -9.10% | $4.38B | 0.15% |
KMLM | -8.44% | $353.87M | 0.9% |
FMF | -7.62% | $244.61M | 0.95% |
XHLF | -7.48% | $874.27M | 0.03% |
CTA | -7.44% | $350.27M | 0.78% |
KCCA | -6.91% | $220.51M | 0.87% |
XBIL | -6.70% | $637.70M | 0.15% |
DBO | -6.56% | $217.57M | 0.77% |
BILZ | -6.32% | $563.02M | 0.14% |
BSCO | -6.05% | $2.35B | 0.1% |
DBE | -5.79% | $50.13M | 0.77% |
DBA | -4.72% | $755.88M | 0.93% |
WEAT | -4.63% | $120.27M | 0.28% |
FBY | -3.65% | $127.69M | 0.99% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FTGC | 0.08% | $2.17B | 1.02% |
DBMF | 0.09% | $1.02B | 0.85% |
CLOI | 0.56% | $715.40M | 0.4% |
IBTE | 0.75% | $1.70B | 0.07% |
CORN | -0.95% | $61.12M | 0.2% |
CANE | 1.42% | $17.72M | 0.29% |
DUSB | -1.52% | $797.63M | 0.15% |
CCOR | -1.56% | $109.04M | 1.18% |
SGOV | -1.63% | $27.53B | 0.09% |
XONE | 1.66% | $548.88M | 0.03% |
TBLL | 1.67% | $1.92B | 0.08% |
SHV | -1.71% | $18.13B | 0.15% |
HDRO | -1.78% | $164.26M | 0.3% |
MUST | 2.20% | $410.00M | 0.23% |
CSHI | 2.21% | $482.85M | 0.38% |
DBC | -2.24% | $1.39B | 0.87% |
GSG | -2.28% | $914.42M | 0.75% |
MINT | -2.29% | $11.62B | 0.35% |
USCI | -2.36% | $185.47M | 1.07% |
AGZD | -2.48% | $142.76M | 0.23% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BBH | 50.45% | $397.87M | 0.35% |
GNOM | 48.68% | $70.59M | 0.5% |
IBB | 47.77% | $6.66B | 0.45% |
FBT | 45.60% | $1.11B | 0.56% |
ARKG | 42.95% | $1.13B | 0.75% |
WOOD | 41.48% | $175.10M | 0.41% |
VXF | 41.18% | $21.54B | 0.06% |
SMLF | 41.12% | $1.44B | 0.15% |
RDVY | 41.08% | $12.93B | 0.49% |
IJJ | 40.93% | $8.03B | 0.18% |
ARKK | 40.91% | $6.28B | 0.75% |
VIOV | 40.68% | $1.44B | 0.15% |
ESML | 40.57% | $1.90B | 0.17% |
VBK | 40.51% | $19.31B | 0.07% |
IVOV | 40.49% | $964.95M | 0.15% |
IJS | 40.13% | $7.37B | 0.18% |
QQA | 39.82% | $135.01M | 0% |
QCLN | 39.82% | $574.08M | 0.59% |
ROBT | 39.75% | $441.35M | 0.65% |
HFND | 39.69% | $34.86M | 1.22% |